ATLANTIS Trial | Stroke
Volunteers wanted to participate in antibody clinical trial
ASCO GU 2022: Discussion on the ATLANTIS and BAYOU Trials in Advanced Urothelial Cancer
C. Michael Gibson MD on Twitter: "Dr. Jean-Philippe Collet presents the results of the ATLANTIS trial: Net clinical benefit of Apixaban after TAVI is not superior to SOC antithrombotic treatment. Full slide
ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line | Future Oncology
Top Interventional Trials presented at ACC.21
Andrew M. Goldsweig, MD, MS on Twitter: "LAAOS III, PARADISE-MI, ATLANTIS, TRISCEND...and more! Late-breaking clinical trials are coming at #ACC21! See you tomorrow at https://t.co/IYN26oyRKP! https://t.co/l8DVyMXarB" / Twitter
Top Interventional Trials presented at ACC.21
Cover Story | Big Data ADAPTABLE Trial Reveals a New Future For Clinical Trials - American College of Cardiology
A trial of more treatment after chemotherapy for advanced urinary tract cancer (urothelial cancer) (ATLANTIS) | Cancer Research UK
The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI - Cardiac Interventions Today
Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC | tctmd.com
The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI - Cardiac Interventions Today
A trial of more treatment after chemotherapy for advanced urinary tract cancer (urothelial cancer) (ATLANTIS) | Cancer Research UK
Is Lupin Atlantis Holdings S.A. late reporting EU clinical trials?
Study design for patients in ATLANTIS trial. Abbreviations: MET MET... | Download Scientific Diagram
The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI - Cardiac Interventions Today
ASCO GU 2022: A Randomized, Double Blind, Biomarker Selected, Phase II Clinical Trial of Maintenance PARP Inhibition Following Chemotherapy for Metastatic Urothelial Carcinoma: Final Analysis of the ATLANTIS Rucaparib Arm
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study - The Lancet Respiratory Medicine
ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI | tctmd.com
Davide Capodanno on Twitter: "In #ATLANTIS, apixaban did not reduce a composite of thrombotic, ischemic or bleeding events compared with standard of care (i.e., VKA in patients with baseline indication to OAC,
ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer | Trials | Full Text
ATLANTIS - Capsule Summary Slidesets - WCLC Highlights - WCLC 2021 - Oncology - Clinical Care Options
CPFT joins pioneering trial for schizophrenia treatment | Cambridge Network
Oral anti‐Xa anticoagulation after trans‐aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial | Semantic Scholar
Despite Failure to Meet Phase III Primary Endpoint, Jazz's SCLC Drug Holds Promise | BioSpace
